Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes.

Neugebauer R, Fireman B, Roy JA, O'Connor PJ, Selby JV.

Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:99-113. doi: 10.1002/pds.3253. Erratum in: Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1361.

PMID:
22552985
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.
5.

Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus.

Kruger DF, Boucher JL, Banerji MA.

Postgrad Med. 2011 Jul;123(4):54-62. doi: 10.3810/pgm.2011.07.2304. Review.

PMID:
21680989
6.

The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitus.

Asche CV, Bode B, Busk AK, Nair SR.

Diabetes Obes Metab. 2012 Jan;14(1):47-57. doi: 10.1111/j.1463-1326.2011.01487.x. Epub 2011 Nov 22. Review.

PMID:
21834876
7.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
8.

The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review.

Best JH, Lavillotti K, DeYoung MB, Garrison LP.

Diabetes Obes Metab. 2012 May;14(5):387-98. doi: 10.1111/j.1463-1326.2011.01533.x. Epub 2011 Dec 27. Review.

PMID:
22074017
9.

Importance of glucose control.

Edelman SV.

Med Clin North Am. 1998 Jul;82(4):665-87. Review.

PMID:
9706116
10.
11.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
12.

Structural equation modeling versus marginal structural modeling for assessing mediation in the presence of posttreatment confounding.

Moerkerke B, Loeys T, Vansteelandt S.

Psychol Methods. 2015 Jun;20(2):204-20. doi: 10.1037/a0036368. Epub 2015 Mar 9. Review.

PMID:
25751514
13.

[Time-dependent confounding in the estimation of treatment effects in randomised trials with multimodal therapies--an illustration of the problem of time-dependent confounding by causal graphs].

Zietemann VD, Schuster T, Duell TH.

Gesundheitswesen. 2015 Jan;77(1):62-6. doi: 10.1055/s-0033-1355405. Epub 2013 Nov 7. Review. German.

PMID:
24203687
14.

Dynamic microsimulation models for health outcomes: a review.

Rutter CM, Zaslavsky AM, Feuer EJ.

Med Decis Making. 2011 Jan-Feb;31(1):10-8. doi: 10.1177/0272989X10369005. Epub 2010 May 18. Review.

15.

Provider behavior and treatment intensification in diabetes care.

Resnick HE, Chernew ME.

Am J Manag Care. 2015 Jun 1;21(6):e399-404. Review.

16.

Instrumental variable methods in comparative safety and effectiveness research.

Brookhart MA, Rassen JA, Schneeweiss S.

Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):537-54. doi: 10.1002/pds.1908. Review.

17.

Adaptive treatment strategies in chronic disease.

Lavori PW, Dawson R.

Annu Rev Med. 2008;59:443-53. Review.

18.

Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide.

Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, editors.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jan.

19.

Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control.

Wood ME, Lapane KL, van Gelder MMHJ, Rai D, Nordeng HME.

Pharmacoepidemiol Drug Saf. 2017 Oct 17. doi: 10.1002/pds.4336. [Epub ahead of print] Review.

PMID:
29044735

Supplemental Content

Support Center